Perry A. Karsen

2014

In 2014, Perry A. Karsen earned a total compensation of $7.3M as Chief Executive Officer, CCT at Celgene, a 3% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$4,122,514
Option Awards$2,077,620
Salary$666,500
Stock Awards$368,088
Other$24,440
Total$7,259,162

Karsen received $4.1M in non-equity incentive plan, accounting for 57% of the total pay in 2014.

Karsen also received $2.1M in option awards, $666.5K in salary, $368.1K in stock awards and $24.4K in other compensation.

Rankings

In 2014, Perry A. Karsen's compensation ranked 907th out of 13,032 executives tracked by ExecPay. In other words, Karsen earned more than 93.0% of executives.

ClassificationRankingPercentile
All
907
out of 13,032
93rd
Division
Manufacturing
322
out of 4,966
94th
Major group
Chemicals And Allied Products
107
out of 1,686
94th
Industry group
Drugs
83
out of 1,365
94th
Industry
Pharmaceutical Preparations
75
out of 1,043
93rd
Source: SEC filing on April 30, 2015.

Karsen's colleagues

We found six more compensation records of executives who worked with Perry A. Karsen at Celgene in 2014.

2014

Robert Hugin

Celgene

Chief Executive Officer

2014

Peter Kellogg

Celgene

Chief Financial Officer

2014

Jacqualyn Fouse

Celgene

President Hematology and Oncology

2014

Mark Alles

Celgene

Chief Operating Officer

2014

Thomas Daniel

Celgene

Chairman

2014

Scott Smith

Celgene

President, Immunology & Inflammation

You may also like